Schoenherr Thomas Edward

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 8. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 8
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Tempus AI, Inc.CEO, DiagnosticsOpen-market sell$873,88510,281 sharesSep 29, 2026Tempus AI, Inc.CEO, Diagnostics$873,885Sell · Sep 29Open-market sell10,281Sep 29, 2026
Tempus AI, Inc.CEO, DiagnosticsOpen-market sell$30,248494 sharesAug 20, 2026Tempus AI, Inc.CEO, Diagnostics$30,248Sell · Aug 20Open-market sell494Aug 20, 2026
Tempus AI, Inc.CEO, DiagnosticsOpen-market sell$54,405900 sharesAug 20, 2026Tempus AI, Inc.CEO, Diagnostics$54,405Sell · Aug 20Open-market sell900Aug 20, 2026
Tempus AI, Inc.CEO, DiagnosticsOpen-market sell$179,5502,994 sharesAug 20, 2026Tempus AI, Inc.CEO, Diagnostics$179,550Sell · Aug 20Open-market sell2,994Aug 20, 2026
Tempus AI, Inc.CEO, DiagnosticsOpen-market sell$28,970500 sharesAug 20, 2026Tempus AI, Inc.CEO, Diagnostics$28,970Sell · Aug 20Open-market sell500Aug 20, 2026